Challenges in Matrix Metalloproteinases Inhibition
Helena Laronha, Inês Carpinteiro, Jaime Portugal, Ana Mano Azul, Mário Polido, Krasimira T. Petrova, Madalena Salema‐Oom, Jorge Caldeira
Abstract
Matrix metalloproteinases are enzymes that degrade the extracellular matrix. They have different substrates but similar structural organization. Matrix metalloproteinases are involved in many physiological and pathological processes and there is a need to develop inhibitors for these enzymes in order to modulate the degradation of the extracellular matrix (ECM). There exist two classes of inhibitors: endogenous and synthetics. The development of synthetic inhibitors remains a great challenge due to the low selectivity and specificity, side effects in clinical trials, and instability. An extensive review of currently reported synthetic inhibitors and description of their properties is presented.